If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMitchells & Butlers Regulatory News (MAB)

Share Price Information for Mitchells & Butlers (MAB)

Share Price is delayed by 15 minutes
Get Live Data
254.50    1.50 (0.59%)
Bid:
255.00
Ask:
256.00
Spread: 1.00 (0.392%)
Market Cap: £1.51b
MAB Live PriceLast checked at - London Stock Exchange

Intraday Mitchells & Butlers Share Chart

Form 8.5 Mitchells & Bulters Plc

13 Oct 2011 08:08

RNS Number : 1113Q
Nomura International PLC (EPT)
13 October 2011
 



FORM 8.5 (EPT/NON-RI)

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Nomura International Plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Mitchells & Butlers Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Mitchells & Butlers Plc

(d) Date position held/dealing undertaken:

12 October 2011

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

NO

 

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

8 13/24p ordinary shares

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

205,104

0.050%

129,204

0.032%

(2) Derivatives (other than options):

(3) Options and agreements to purchase/sell:

 

TOTAL:

205,104

0.050%

129,204

0.032%

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

Ordinary Shares

Purchase

5,163

2.505

Ordinary Shares

Purchase

434

2.506

Ordinary Shares

Purchase

437

2.512

Ordinary Shares

Purchase

3,041

2.518

Ordinary Shares

Purchase

14,479

2.525

Ordinary Shares

Purchase

700

2.526

Ordinary Shares

Purchase

5,514

2.528

Ordinary Shares

Purchase

923

2.529

Ordinary Shares

Purchase

5,893

2.531

Ordinary Shares

Purchase

3,183

2.532

Ordinary Shares

Purchase

1,700

2.533

Ordinary Shares

Purchase

2,662

2.534

Ordinary Shares

Purchase

1,408

2.535

Ordinary Shares

Purchase

1,274

2.537

Ordinary Shares

Purchase

13,675

2.539

Ordinary Shares

Purchase

1,593

2.541

Ordinary Shares

Purchase

1,712

2.542

Ordinary Shares

Purchase

1,426

2.543

Ordinary Shares

Purchase

900

2.544

Ordinary Shares

Purchase

243

2.545

Ordinary Shares

Purchase

5,697

2.546

Ordinary Shares

Purchase

7,050

2.550

Ordinary Shares

Purchase

4,949

2.551

Ordinary Shares

Purchase

1,265

2.554

Ordinary Shares

Purchase

5,693

2.555

Ordinary Shares

Purchase

8,535

2.558

Ordinary Shares

Purchase

1,271

2.560

Ordinary Shares

Purchase

9,109

2.561

Ordinary Shares

Purchase

4,259

2.562

Ordinary Shares

Purchase

1,271

2.563

Ordinary Shares

Purchase

12,320

2.564

Ordinary Shares

Purchase

1,650

2.566

Ordinary Shares

Purchase

1,274

2.567

Ordinary Shares

Purchase

400

2.568

Ordinary Shares

Purchase

2,542

2.569

Ordinary Shares

Purchase

339

2.571

Ordinary Shares

Purchase

2,409

2.572

Ordinary Shares

Purchase

858

2.573

Ordinary Shares

Purchase

696

2.575

Ordinary Shares

Purchase

1,871

2.577

Ordinary Shares

Sale

2,211

2.505

Ordinary Shares

Sale

2,798

2.506

Ordinary Shares

Sale

703

2.522

Ordinary Shares

Sale

175

2.523

Ordinary Shares

Sale

17,503

2.525

Ordinary Shares

Sale

1,344

2.526

Ordinary Shares

Sale

3,569

2.530

Ordinary Shares

Sale

589

2.532

Ordinary Shares

Sale

1,589

2.533

Ordinary Shares

Sale

391

2.534

Ordinary Shares

Sale

328

2.539

Ordinary Shares

Sale

1,110

2.541

Ordinary Shares

Sale

7,736

2.542

Ordinary Shares

Sale

201

2.543

Ordinary Shares

Sale

1,167

2.544

Ordinary Shares

Sale

391

2.546

Ordinary Shares

Sale

1,717

2.547

Ordinary Shares

Sale

11,873

2.548

Ordinary Shares

Sale

1,277

2.549

Ordinary Shares

Sale

34,796

2.550

Ordinary Shares

Sale

1,401

2.551

Ordinary Shares

Sale

897

2.553

Ordinary Shares

Sale

1,329

2.554

Ordinary Shares

Sale

2,146

2.555

Ordinary Shares

Sale

4,997

2.556

Ordinary Shares

Sale

439

2.557

Ordinary Shares

Sale

251

2.558

Ordinary Shares

Sale

632

2.559

Ordinary Shares

Sale

1,528

2.560

Ordinary Shares

Sale

7,009

2.561

Ordinary Shares

Sale

2,270

2.562

Ordinary Shares

Sale

1,317

2.563

Ordinary Shares

Sale

766

2.566

Ordinary Shares

Sale

1,215

2.568

Ordinary Shares

Sale

2,787

2.569

Ordinary Shares

Sale

7,883

2.570

Ordinary Shares

Sale

261

2.574

Ordinary Shares

Sale

1,912

2.575

 

TOTAL BUY - 139,818

TOTAL SELL - 130,508

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

13 October 2011

Contact name:

Kyere Tabiri

Telephone number:

020 7102 1267

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEODKNDKOBDKOKD
Date   Source Headline
30th Jun 20222:00 pmRNSTotal Voting Rights
27th Jun 20224:28 pmRNSDirector/PDMR Shareholding
21st Jun 20221:00 pmRNSDirector/PDMR Shareholding
31st May 202211:00 amRNSTotal Voting Rights
30th May 20222:00 pmRNSDirector/PDMR Shareholding
18th May 20227:00 amRNSHalf Year Results
13th May 202211:00 amRNSNotice of Half Year Results
4th May 202210:00 amRNSDirector/PDMR Shareholding
29th Apr 202211:45 amRNSTotal Voting Rights
4th Apr 202212:15 pmRNSDirector/PDMR Shareholding
1st Apr 202211:45 amRNSBlock listing Interim Review
1st Apr 202211:00 amRNSTotal Voting Rights
8th Mar 202212:00 pmRNSDirector/PDMR Shareholding
4th Mar 202210:30 amRNSBoard Appointment
28th Feb 202211:27 amRNSTotal Voting Rights
7th Feb 20223:00 pmRNSDirector/PDMR Shareholding
31st Jan 20222:00 pmRNSTotal Voting Rights
25th Jan 20221:15 pmRNSResult of Annual General Meeting
13th Jan 20227:00 amRNSFirst Quarter Trading Update
12th Jan 202212:00 pmRNSNotice of first quarter trading update
10th Jan 20224:15 pmRNSDirector/PDMR Shareholding
31st Dec 202112:20 pmRNSTotal Voting Rights
23rd Dec 202112:20 pmRNSBoard Changes
23rd Dec 202112:00 pmRNSAnnual Report 2021
13th Dec 20213:30 pmRNSDirector/PDMR Shareholding
7th Dec 202110:00 amRNSDirector/PDMR Shareholding
30th Nov 20213:45 pmRNSTotal Voting Rights
29th Nov 20212:00 pmRNSDirector/PDMR Shareholding
25th Nov 20212:30 pmRNSDirector/PDMR Shareholding
25th Nov 20217:00 amRNSFull Year Results
22nd Nov 20212:30 pmRNSNotice of Final Results
15th Nov 202112:45 pmRNSDirector/PDMR Shareholding
29th Oct 20212:00 pmRNSTotal Voting Rights
18th Oct 20212:15 pmRNSDirector/PDMR Shareholding
1st Oct 20212:35 pmRNSBlock listing Interim Review
1st Oct 20212:30 pmRNSDirector/PDMR Shareholding
30th Sep 202110:43 amRNSTotal Voting Rights
23rd Sep 20217:00 amRNSPre-Close Trading Update
22nd Sep 20211:00 pmRNSNotice of Pre-Close Trading Statement
20th Sep 20212:00 pmRNSDirector/PDMR Shareholding
31st Aug 20212:15 pmRNSTotal Voting Rights
24th Aug 20211:30 pmRNSHolding(s) in Company
23rd Aug 20212:15 pmRNSDirector/PDMR Shareholding
30th Jul 20212:00 pmRNSTotal Voting Rights
29th Jul 20217:00 amRNSThird Quarter Trading Update
26th Jul 20212:15 pmRNSDirector/PDMR Shareholding
26th Jul 202112:00 pmRNSNotice of Third Quarter Trading Update
15th Jul 202110:00 amRNSBoard Changes update
7th Jul 202111:00 amRNSAdditional Listing
1st Jul 202111:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.